Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Accendra Health, Inc. before investing.

In this article, we go over a few key elements for understanding Accendra Health, Inc.’s stock price such as:

• Accendra Health, Inc.’s current stock price and volume
• Why Accendra Health, Inc.’s stock price changed recently
• Upgrades and downgrades for ACH from analysts
• ACH’s stock price momentum as measured by its relative strength

About Accendra Health, Inc. (ACH)

Before we jump into Accendra Health, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Want to learn more about Accendra Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Accendra Health, Inc..

Accendra Health, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Accendra Health, Inc.’s stock price was $3.090.

Accendra Health, Inc. is down 7.49% from its previous closing price of $3.340.

During the last market session, Accendra Health, Inc.’s stock traded between $3.000 and $3.380. Currently, there are approximately 76.43 million shares outstanding for Accendra Health, Inc..

Accendra Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Accendra Health, Inc. Stock Price History

Accendra Health, Inc.’s (ACH) price is currently down 9.65% so far this month.

During the month of July, Accendra Health, Inc.’s stock price has reached a high of $3.840 and a low of $2.970.

Over the last year, Accendra Health, Inc. has hit prices as high as $7.240 and as low as $1.840.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Accendra Health, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Accendra Health, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Accendra Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Accendra Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Accendra Health, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Accendra Health, Inc. (ACH) by visiting AAII Stock Evaluator.

Relative Price Strength of Accendra Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Accendra Health, Inc. has a weighted four-quarter relative price strength of -9.15%, which translates to a Momentum Score of 25 and is considered to be Weak.

Want to learn more about how Accendra Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Accendra Health, Inc. Stock Price: Bottom Line

As of July 31, 2026, Accendra Health, Inc.’s stock price is $3.090, which is down 7.49% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Accendra Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.